Clinical characteristics of metastatic castration-resistant prostate cancer (mCRPC) patients with DNA repair (DNAr) defects.

Michael Kolinsky,Joaquin Mateo,Semini Sumanasuriya,Pasquale Rescigno,Diletta Bianchini,Zafeiris Zafeiriou,Raquel Perez Lopez,Nina Tunariu,Niven Mehra,Anuradha Jayaram,Suzanne Carreira,Susana Miranda,Penelope Flohr,Ruth Riisnaes,Jane Goodall,Gunther Boysen,Johann S. de Bono

Clinical characteristics of metastatic castration-resistant prostate cancer (mCRPC) patients with DNA repair (DNAr) defects.

2016

Michael Kolinsky
Joaquin Mateo
Semini Sumanasuriya
Pasquale Rescigno
Diletta Bianchini
Zafeiris Zafeiriou
Raquel Perez Lopez
Nina Tunariu
Niven Mehra
Anuradha Jayaram
Suzanne Carreira
Susana Miranda
Penelope Flohr
Ruth Riisnaes
Jane Goodall
Gunther Boysen
Johann S. de Bono

5028Background: Recent data show that 20-30% of mCRPC patients have defects in DNAr genes. We have evaluated the clinical phenotype of these patients. Methods: Medical records of mCRPC patients tre...

Keywords:

DNA repair
Prostate cancer
Pathology
Cancer research
Castration
Medicine
Medical record
Oncology
castration resistant
Internal medicine
clinical phenotype

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations